Withings, the healthcare technology company known for its remote monitoring devices, announced that the U.S. Food and Drug Administration (FDA) has cleared its newest smart scale, the Body Scan Connected Health Station.
Body Scan includes a high-strength glass platform with four weight sensors and 14 ITO electrodes and a retractable handle that includes four additional stainless steel electrodes for performing 6-lead electrocardiograms. The device evaluates a user’s body composition, heart rate and vascular age, and it was designed to identify any signs of atrial fibrillation (AFib). Body Scan also gives users access to personalized recommendations and can connect directly with a healthcare specialists when needed.
Once Body Scan’s sensors perform an ECG, the devices use advanced artificial intelligence to identify and track heart patterns known to be found in AFib patients. The results are displayed both on the device’s LCD screen and the user’s smartphone application. These results are saved, allowing them to be compared as time goes on, and they can be shared directly with healthcare providers.